Causes inh induced inhibition of metabolism and elevation of serum levels, causing toxicity. The purpose of the study is to measure the drug levels in the blood of hivinfected individuals taking anti hiv medication efavirenz 400 mg once daily in the presence of antitb medication rifampicin and isoniazid. With its virtual lack of toxicity in the recommended doses of 3 to 5 mg. Isoniazid undergoes extensive metabolism that takes place in the mucosal cells of the small intestine and in the liver. The available pharmacokinetic data on antitubercular drugs in children raises the concern of suboptimal plasma concentrations attained when doses extrapolated from adult studies are used. Tb is a bacterial infection which mostly affects the lungs, but which can affect any part of your body. Concurrentadministration of pyridoxinemay prevent neuropathy. Population pharmacokinetic analysis of isoniazid, acetylisoniazid. Pharmacokinetic data were obtained from perinatally hivexposed south african infants aged 324 months receiving inh 1020 mgkg. Isoniazid inh is highly effective for the management of tuberculosis. Carbamazepine levels should be determined prior to concurrent administration with isoniazid, signs and symptoms of carbamazepine toxicity should be monitored closely and appropriate dosage adjustment of the anticonvulsant should be made 3. Clinical pharmacokinetics of isoniazid springerlink. Isoniazid pharmacokinetics, pharmacodynamics, and dosing. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is.
Perhaps the most important drug of all is isoniazid. Rifampin, isoniazid, pyrazinamide, and ethambutol combination is indicated in the initial phase of the shortcourse treatment of tuberculosis. Inclusion of isoniazid in the regimen of patients with strain w mdrtb was also associated with improved outcomes. The drug also passes through the placental barrier and into milk in concentrations comparable to those in the plasma. Be alert for signs of peripheral neuropathy numbness, tingling, decreased muscle strength. Isoniazid therapy is often associated with minor, transient and asymptomatic elevations in serum aminotransferase levels but, more importantly, isoniazid is a well known cause of acute clinically apparent liver injury which can be severe and is sometimes fatal. The major metabolic route for the formation of isonicotinic acid from isoniazid was via acetylisoniazid. Inhibition of cytochrome p450 cyp450 isoforms by isoniazid. Drug metabolism is conventionally described as consisting of phase 1 oxidation reactions, primarily mediated by cytochrome p450 enzymes in the liver, and phase 2 conjugations such as glucuronidation, sulphation and acetylation.
Also, there is lack of consensus regarding the effect of malnutrition on pharmacokinetics of antitubercular drugs in children. Isoniazid pharmacokinetics and metabolism in patients coinfected with tuberculosis and hiv. Transplacental pharmacokinetics of the antitubercu. A recent preliminary result suggested that impaired isoniazid metabolism is. Overdose of isoniazid inh, an antituberculosis drug, can be lifethreatening because of neurotoxicity. An analysis of inh ab positivity by ethnicity, drug metabolism. Genetic polymorphisms, drug metabolism and drug concentrations.
The study is being run in twostages london stage 1 and kampala stage 2. What you need to know about your medicine for latent. Benzodiazepines such as diazepam, carbamazepine, phenytoin. Determination of clinical factors affecting isoniazid pharmacokinetics and metabolic pathways. Pronounced interindividual variation in circulating isoniazid concentration and clearance which occur after dosing with the drug are associated with hereditary differences in the acetylalor status. Aluminumcontaining antacids may decrease absorption. Clinically significant drug interactions with antituberculosis agents. Isoniazid metabolism and hepatotoxicity sciencedirect. The primary objective of drug metabolism is to facilitate a drugs excretion by increasing its water solubility hydrophilicity. A high dose of isoniazid disturbs endobiotic homeostasis.
However, it can cause liver injury and even liver failure. Isoniazid is known to slow the metabolism of carbamazepine and increase its serum levels. Inh metabolism has been thought to be associated with inhinduced. Cytochrome p450 p450 bioactivation of arachidonic acid to hydroxyeicosatetraenoic acids hetes has been reported to be isoform and tissuespecific. Rifater rifampin, isoniazid and pyrazinamide usp tablets. The involved chemical modifications incidentally decrease or increase a drugs pharmacological activity andor halflife, the most extreme example being the metabolic activation of inactive prodrugs into active drugs, e. Get emergency medical help if you have signs of an allergic reaction hives, difficult breathing, swelling in your face or throat or a severe skin reaction fever, sore throat, burning in your eyes, skin pain, red or purple skin rash that spreads and causes blistering and peeling seek medical treatment if you have a serious drug reaction that can affect many parts. The most current report from the druginduced liver injury network dili indicates that the true incidence of inhinduced liver injury is largely. Overdose of isoniazid inh, an antituberculosis drug, can be life. Isoniazid is a medicine used alone or with other drugs to treat or prevent tuberculosis tb tb is an infectious disease that mainly impacts the lungs. The potent antituberculous effects of this drug have quickly been applied in clinical practice. Significant drug interactions with tuberculosis medications rifampin rifabutin rifapentine. Pubchem id 3767 1 is a firstline antimycobacterial agent used to treat active or latent tuberculosis tb infections.
Isoniazid and ethionamide are common antituberculosis drugs. Inh, rifampicin rif, pyrazinamide pza and ethambutol emb. However, the exact role of cyp3a in inh metabolism, bioactivation and toxicity remains. Isonicotinic acid hydrazide activity against tb, mechanism of action, and metabolism bactericidal. In the current study, we used an untargeted metabolomic approach to. Pharmacokinetics of isoniazid metabolism in man springerlink. Rifampin, isoniazid, pyrazinamide, and ethambutol drug. If it is still the same day, take the dose as soon as you remember.
Isoniazid inh, a firstline drug for tuberculosis control, frequently causes liver injury. Consult your healthcare professional before taking or discontinuing any drug or. The standard therapies for tb include a combination treatment of isoniazid inh, rifampicin, pyrazinamide, and ethambutol2. Inh metabolism has been thought to be associated with inhinduced liver injury.
Isoniazid side effects, dosage, interactions drugs. Role of cyp3a in isoniazid metabolism in vivo ncbi. Isoniazid daily every day 9 months twice weekly m t w th f s sun your doctor may have you take vitamin b6 with your medicine. Isoniazid is contraindicated in patients who develop severe hypersensitivity reactions, including druginduced hepatitis. When the bacterial strain becomes resistant to one. The pharmacokinetics of isoniazid in man are described. When isoniazid is to be taken 2 times a week, it should be given by directly observed therapy dot.
As a result, these two drugs have a similar metabolism, toxicity and molecular targets, causing concern for potential crossreactivity reactions. Pdf isoniazid metabolism and hepatotoxicity researchgate. Isoniazid inh is a firstline drug for tuberculosis control. It is treatable with a course of medicines which usually lasts for six months in total. A high dose of isoniazid disturbs endobiotic homeostasis in mouse.
The standard therapies for tb include a combination treatment of isoniazid inh, rifampicin, pyrazinamide, and ethambutol 2. You will need to take several medicines to treat tb isoniazid is just one of the medicines prescribed. The pharmacokinetics of inh, acinh, and ina were analyzed using nonlinear. To determine whether altered p450 expression affects the production of these metabolites, the formation of hetes after isoniazidmediated cyp2e1 induction was evaluated in the rat liver and kidney. Introduction the wellestablished field of pharmacogenetics is a direct precursor of per sonalised or stratified medicine 1, 2.
The variations in rate of isoniazid inactivation and elimination in different rapid and slow acetylator phenotypes are primarily due to. Slow acetylation may lead to higher blood levels of the drug and thus, to an increase in toxic reactions. Significant drug interactions with tuberculosis medications. During this phase, which should last 2 to 3 months, rifampin, isoniazid, pyrazinamide, and ethambutol combination should. The plasma halflife of isoniazid in patients with normal renal and hepatic function ranges from 1 to 4 hours, depending on the rate of metabolism. We conducted this study with the aims of determining the plasma. Although this phenomenon for most drugs involved has been attributed to liver uptake andor metabolism, a large part of the effect for isoniazid may be due to. Fixed combination preparation containing rifampin, isoniazid, and pyrazinamide rifater is used for treatment of pulmonary tb.
Hi the rate of this alteration while constant for anyone person varies from one individual to another. Establish baseline electroneuromyographic values at the beginning of drug treatment whenever possible, and reexamine these values periodically to document druginduced changes in peripheral nerve function. Inh metabolism has been thought to be associated with inh induced. In clinical practice for management of inh overdose and acute toxicity, the potential of inhinduced hepatotoxicity is also considered. However, the biochemical basis of acute inh toxicity in the liver remains elusive. Isoniazid is not substantially bound to plasma proteins. Isoniazid is distributed in the body with an apparent volume of distribution volume of 0. Isoniazid diffuses throughout total body water, even the central nervous system.
The rate of acetylation does not significantly alter the effectiveness of isoniazid. This information is generalized and not intended as specific medical advice. There are limited data on isoniazid inh pharmacokinetics in infants and young children and, therefore, uncertainty on appropriate dosing. Detailed pharmacokinetic studies undertaken on a slow and a rapid acetylator of isoniazid enabled approximate firstorder rate constants to be calculated for the metabolic processes involved in the conversion of isoniazid to acetylisoniazid, isonicotinic acid, isonicotinylglycine, monoacetylhydrazine, and diacetylhydrazine, and their excretion in the urine. Isoniazid is the most reliable and most commonly used medication for tuberculosis. Despite the beneficial effects of inh, severe adverse effects especially peripheral neuropathy and hepatotoxicity are associated with inh therapies4, 5, 6, 7. However, variability in isoniazid pharmacokinetics can result in hepatotoxicity or treatment failure. The defect in slow acetylators of isoniazid and similar amines appears to be caused by the synthesis of less enzyme rather than an abnormal form of it. Pharmacokinetics of isoniazid, rifampicin, pyrazinamide. Toxicity, drug metabolism, tuberculosis, isoniazid, acetylation, catalytic triad, acetyl coa, arylamine, gene polymorphism. Targeted tuberculin testing and treatment of latent tuberculosis infection.
293 1285 719 1149 1226 612 1057 841 594 938 683 1596 663 1083 561 742 711 656 1054 709 216 629 538 232 842 125 881 234 857 1381 345 1427 771 476 1046 732 1041 340 855 961 860 931 1465 1285 168 1305 1472 883 750